Suppr超能文献

Summary report of the First International Conference on inhibitors in haemophilia A.

作者信息

Lacroix-Desmazes Sebastien, Scott David W, Goudemand Jenny, Van Den Berg Marijke, Makris Michael, Van Velzen Alice S, Santagostino Elena, Lillicrap David, Rosendaal Frits R, Hilger Anneliese, Sauna Zuben E, Oldenburg Johannes, Mantovani Lorenzo, Mancuso M Elisa, Kessler Craig, Hay Charles R M, Knoebl Paul, Di Minno Giovanni, Hoots Keith, Bok Amanda, Brooker Mark, Buoso Erica, Mannucci Pier Mannuccio, Peyvandi Flora

机构信息

National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Medicale - INSERM), Paris, France.

Department of Medicine (MED), Uniformed Service University of Health Sciences, Bethesda, MD, United States of America.

出版信息

Blood Transfus. 2017 Oct;15(6):568-576. doi: 10.2450/2016.0252-16. Epub 2016 Nov 25.

DOI:10.2450/2016.0252-16
PMID:27893354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649967/
Abstract
摘要

相似文献

1
Summary report of the First International Conference on inhibitors in haemophilia A.
Blood Transfus. 2017 Oct;15(6):568-576. doi: 10.2450/2016.0252-16. Epub 2016 Nov 25.
2
Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
Haemophilia. 2014 Nov;20(6):e414-7. doi: 10.1111/hae.12521. Epub 2014 Oct 21.
3
Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.
Clin Rev Allergy Immunol. 2009 Oct;37(2):114-24. doi: 10.1007/s12016-009-8122-5.
4
Long-term treatment course of a patient with mild haemophilia A who developed a high titre factor VIII inhibitor.
Haemophilia. 2014 Nov;20(6):e402-4. doi: 10.1111/hae.12491.
5
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
Br J Haematol. 2007 Jan;136(1):12-25. doi: 10.1111/j.1365-2141.2006.06359.x.
6
Management of factor VIII inhibitors.
Best Pract Res Clin Haematol. 2006;19(1):51-66. doi: 10.1016/j.beha.2005.03.002.
7
Haemophilia A and inhibitors: advances in prevention and ITI treatment optimization.
Haemophilia. 2014 Sep;20 Suppl 6:1. doi: 10.1111/hae.12464.
8
Statistical modelling issues in the RODIN study.
Haemophilia. 2014 Jul;20(4):e351-2. doi: 10.1111/hae.12458. Epub 2014 May 14.
9
Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.
Haemophilia. 2010 Nov;16(6):892-901. doi: 10.1111/j.1365-2516.2010.02272.x.
10
Is oral tolerance therapy possible for haemophilia with inhibitors?
Vox Sang. 2001 Jan;80(1):61-2. doi: 10.1046/j.1423-0410.2001.00007.x.

引用本文的文献

1
Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1.
Front Immunol. 2020 Apr 15;11:620. doi: 10.3389/fimmu.2020.00620. eCollection 2020.
2
"The times they are a-changin", ... or maybe not?
Blood Transfus. 2019 Nov;17(6):401-402. doi: 10.2450/2019.0259-19. Epub 2019 Dec 11.
3
Emicizumab for the treatment of haemophilia A: a narrative review.
Blood Transfus. 2019 May;17(3):223-228. doi: 10.2450/2019.0026-19.
4
Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years.
Blood Transfus. 2019 Sep;17(5):378-384. doi: 10.2450/2019.0253-18. Epub 2018 Feb 4.
5
Mutational Profiles of and in a Cohort of Haemophilia A and Haemophilia B Patients in the Multi-ethnic Malaysian Population.
Mediterr J Hematol Infect Dis. 2018 Sep 1;10(1):e2018056. doi: 10.4084/MJHID.2018.056. eCollection 2018.
6
Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia.
Blood Transfus. 2018 Nov;16(6):525-534. doi: 10.2450/2018.0150-18. Epub 2018 Sep 3.
7
Hemophilia Care in the Pediatric Age.
J Clin Med. 2017 May 19;6(5):54. doi: 10.3390/jcm6050054.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验